2015
DOI: 10.1186/s13620-015-0030-9
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial species isolated from cats with lower urinary tract infection and their susceptibilities to cefovecin

Abstract: BackgroundThe aim of this study was to determine the bacterial species recovered from 61 cats with lower urinary tract infection (LUTI), and their susceptibility to cefovecin in vitro.ResultsThe clinical signs and final clinical diagnosis for cats with confirmed LUTI were also reported. After physical examination of the cats, urine samples including ≥5-6 leucocytes in microscopic evaluation were cultured using bacteriological techniques. The isolates were identified by conventional microbiological methods and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 11 publications
(16 reference statements)
0
7
0
Order By: Relevance
“…However, in this study, male cats showed higher UTI cases than females. UTIs can also occur in healthy male cats that are catheterized, with the risk of infection increases with the duration of catheterization [ 13 , 17 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…However, in this study, male cats showed higher UTI cases than females. UTIs can also occur in healthy male cats that are catheterized, with the risk of infection increases with the duration of catheterization [ 13 , 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…The second highest prevalence was seen in domestic breeds, with 58% having feline UTI. Most cats in our sample were indoor and outdoor cats that had higher risks of infection before drinking water from flower bowls and drains with bacteria infestations [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Cefovecin is a third‐generation cephalosporin currently approved for the treatment of skin infections in domestic dogs and cats in the United States (Stegemann, Passmore, et al, 2006; Stegemann, Sherington, and Blanchflower, et al, 2006; Stegemann, Sherington, Coati, et al, 2006; Stegemann et al, 2007), and additionally for feline urinary tract infections in other countries (Burke et al, 2017; Dokuzeylül et al, 2015; Passmore et al, 2008). Interpretive categories and breakpoints for cefovecin have been established by the Clinical Laboratory Standards Institute (CLSI) for testing pathogens from dogs and cats (CLSI, 2020).…”
Section: Introductionmentioning
confidence: 99%